CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -33.3% | 10,000 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | -25.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | -61.0% | 10,000 | -41.2% | 0.00% | – |
| Q1 2021 | $41,000 | -18.0% | 17,000 | 0.0% | 0.00% | – |
| Q4 2020 | $50,000 | +92.3% | 17,000 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | -52.7% | 17,000 | -23.0% | 0.00% | – |
| Q2 2020 | $55,000 | +22.2% | 22,067 | +0.0% | 0.00% | – |
| Q1 2020 | $45,000 | -42.3% | 22,057 | -12.1% | 0.00% | – |
| Q4 2019 | $78,000 | -25.0% | 25,100 | -19.2% | 0.00% | – |
| Q3 2019 | $104,000 | -12.6% | 31,054 | -16.2% | 0.00% | – |
| Q2 2019 | $119,000 | -11.9% | 37,054 | -21.0% | 0.00% | – |
| Q1 2019 | $135,000 | -42.3% | 46,903 | -19.3% | 0.00% | – |
| Q4 2018 | $234,000 | -17.3% | 58,098 | -4.1% | 0.00% | – |
| Q3 2018 | $283,000 | – | 60,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
| Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
| Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
| Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
| Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
| Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
| FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
| Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
| RBF Capital, LLC | 159,367 | $127,000 | 0.01% |